Golden, BC, May 19, 2016 – Today, teachers from Golden Secondary School from School District 6 (Rocky Mountain), will be trained as instructors to empower students with CPR and defibrillator skills, as well as heart health knowledge, through the award-winning ACT High School CPR and Defibrillator Training Program. This training, held at the secondary school today, will result in all secondary school students graduating with the skills and the knowledge to save lives.
The Advanced Coronary Treatment (ACT) Foundation is the charitable organization that is establishing free CPR and defibrillator training programs in high schools throughout BC and across Canada. ACT is working in partnership with British Columbia Emergency Health Services (BCEHS) paramedics and staff, RBC, AstraZeneca Canada, Pfizer Canada, and Sanofi Canada to bring this program to Golden Secondary School.
Thanks to the support of our partners, the secondary school is receiving training mannequins, AED training units, curriculum materials and program set-up. Today’s teacher training is being provided by BCEHS’ paramedic education officers, Colin Fitzpatrick and Karly Jones, who are volunteering their time to teach the workshop.
“At RBC, we believe the health and wellness of local communities is of vital importance,” said Karen Ball, RBC Royal Bank Manager. “We are proud to be long-time supporters of the ACT Foundation and thrilled to be the community partner bringing CPR and AED training to Golden Secondary School”.
“As a founding partner of the ACT Foundation, we have proudly watched this program expand to communities from coast to coast. Not only are youth learning critical skills that stay with them for a lifetime, they also gain an appreciation of the science behind the techniques and, in some cases, go on to pursue careers in such areas as nursing, medicine, and emergency services,” says Ed Dybka, President and CEO, AstraZeneca Canada.
To date, the ACT High School CPR Program has been established in 226 public standard secondary schools throughout British Columbia and over 281,000 students have already been empowered to save lives with CPR.
“Each and every year the ACT Foundation’s CPR and AED program will enable approximately 44,000 students to gain the information, skills and confidence to save lives. These skills will assist them to help others throughout the rest of their lifetime. An investment worth our efforts,” said Dr. William Dick, Interim Vice President, Medical Programs of BCEHS.
With eight in 10 out-of-hospital cardiac arrests occurring at home or in public places, empowering youth with CPR training as part of their high school education will help increase citizen CPR response rates over the long term. Moreover, early CPR, combined with early defibrillation can increase survival rates for cardiac arrest victims by up to 75%, according to the Heart and Stroke Foundation.
“We are thrilled with the support from our partners,” said Sandra Clarke, the ACT Foundation’s Executive Director. “With it, we can implement the CPR and AED program in Golden. These are lifesaving skills that students will be able to bring to their current and future families and communities.”
To date, the ACT Foundation has set up the ACT High School CPR Program in more than 1,700 high schools nation-wide, empowering more than 3.2 million youth to save lives.
About the ACT Foundation
The ACT Foundation is the national charitable organization that is establishing the CPR and AED program in Canadian high schools. The program is built on ACT’s award-winning community-based model of partnerships and support, whereby ACT finds local partners who donate the mannequins and AED training units that schools need to set up the program. Secondary school teachers then teach CPR and how to use a defibrillator to their students as a regular part of the curriculum, reaching all youth prior to graduation. ACT’s partners who are committed to bringing the program to British Columbia are BC Emergency Health Services (BCEHS) and our national health partners, AstraZeneca Canada, Pfizer Canada and Sanofi Canada.
For further information, please contact: